Intestinal Research

Search: Intest Res Search

CLOSE

Intestinal Research

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).

The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

April 29, 2022

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

Sang Hyoung Park

Intest Res. 2022;20(2):159-164.

Inflammatory bowel disease (IBD) has become a global disease. As IBD is a chronic disease that can result in remarkable morbidity and disability, estimation and understanding the disease burden of...

Review

January 7, 2022

Artificial intelligence for endoscopy in inflammatory bowel disease

Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, et al.

Intest Res. 2022;20(2):165-170.

Inflammatory bowel disease (IBD), with its 2 subtypes, Crohn’s disease and ulcerative colitis, is a complex chronic condition. A precise definition of disease activity and appropriate drug management greatly improve...

Statement

January 5, 2022

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID

Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, et al.

Intest Res. 2022;20(2):171-183.

Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines...

Original Article

May 4, 2021

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis

Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, et al.

Intest Res. 2022;20(2):184-191.

Background/Aims: Intestinal tuberculosis (ITB) is difficult to diagnose due to poor sensitivity of definitive diagnostic tests. ITB may be associated with concomitant pulmonary tuberculosis (PTB) which may remain undetected on...

Original Article

April 29, 2022

Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study

Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, et al.

Intest Res. 2022;20(2):192-202.

Background/Aims: Complementary and alternative medicine (CAM) is prevalent in East Asia. However, information on CAM in East Asian patients with inflammatory bowel disease (IBD) is scarce. We aimed to profile...

Original Article

April 29, 2022

Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study

Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, et al.

Intest Res. 2022;20(2):203-212.

Background/Aims: Fecal S100A12 (FS) and serum S100A12 (SS) have been reported as novel biomarkers that accurately reflect intestinal inflammation. We evaluated if FS and SS in comparison to fecal calprotectin...

Original Article

April 29, 2022

Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia

Chenwen Cai, Juntao Lu, Lijie Lai, et al.

Intest Res. 2022;20(2):213-223.

Background/Aims: The incidence and prevalence of inflammatory bowel disease (IBD) is rising in Asia recently. The study aimed to obtain a comprehensive understanding of the current status of drug therapy...

Original Article

February 8, 2022

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease

Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, et al.

Intest Res. 2022;20(2):224-230.

Background/Aims: Primary sclerosing cholangitis (PSC) is associated with inflammatory bowel disease (IBD). We aimed to evaluate the prevalence, clinical manifestation, and outcomes of PSC in Taiwanese patients with IBD. Methods:...

Original Article

February 8, 2022

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study

Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, et al.

Intest Res. 2022;20(2):231-239.

Background/Aims: Existing therapeutic options for complicated Crohn’s disease (CD) like biologics and surgery are limited by inadequate long-term efficacy, cost, and adverse effects. Tissue hypoxia is important in CD pathogenesis...

Original Article

February 8, 2022

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Fares Ayoub, Matthew Odenwald, Dejan Micic, et al.

Intest Res. 2022;20(2):240-250.

Background/Aims: Perianal fistulas are a debilitating manifestation of Crohn’s disease (CD). Despite the advent of anti-tumor necrosis factor (anti-TNF) therapy, the medical management of fistulizing CD continues to be challenged...

Original Article

February 8, 2022

Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study

Avnish Kumar Seth, Priti Jain

Intest Res. 2022;20(2):251-259.

Background/Aims: To study role of fecal microbiota transplantation (FMT) in induction, maintenance, and rescue in patients with corticosteroid-dependent ulcerative colitis (CDUC). Methods: Patients with active CDUC received 3 fortnightly sessions...

Original Article

April 29, 2022

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study

Yuichi Matsuno, Takehiro Torisu, Junji Umeno, et al.

Intest Res. 2022;20(2):260-268.

Background/Aims: Recent studies suggested a favorable effect of indigo naturalis (IN) in inducing remission for refractory ulcerative colitis (UC), however, the maintenance effect of IN for patients with UC remains...

Current Issue: Volume 20(2); Apr 2022

This archive contains links to the full-text of all issues of Intest Res.

All issues

Vol. 20
2022

v.20(1)
Jan 2022

v.20(2)
Apr 2022

Vol. 19
2021

v.19(1)
Jan 2021

v.19(2)
Apr 2021

v.19(3)
Jul 2021

v.19(4)
Oct 2021

Vol. 18
2020

v.18(1)
Jan 2020

v.18(2)
Apr 2020

v.18(3)
Jul 2020

v.18(4)
Oct 2020

Vol. 17
2019

v.17(1)
Jan 2019

v.17(2)
Apr 2019

v.17(3)
Jul 2019

v.17(4)
Oct 2019

Vol. 16
2018

v.16(1)
Jan 2018

v.16(2)
Apr 2018

v.16(3)
Jul 2018

v.16(4)
Oct 2018

Vol. 15
2017

v.15(1)
Jan 2017

v.15(2)
Apr 2017

v.15(3)
Jul 2017

v.15(4)
Oct 2017

Vol. 14
2016

v.14(1)
Jan 2016

v.14(2)
Apr 2016

v.14(3)
Jul 2016

v.14(4)
Oct 2016

Vol. 13
2015

v.13(1)
Jan 2015

v.13(2)
Apr 2015

v.13(3)
Jul 2015

v.13(4)
Oct 2015

Vol. 12
2014

v.12(1)
Jan 2014

v.12(2)
Apr 2014

v.12(3)
Jul 2014

v.12(4)
Oct 2014

Vol. 11
2013

v.11(1)
Jan 2013

v.11(2)
Apr 2013

v.11(3)
Jul 2013

v.11(4)
Oct 2013

Vol. 10
2012

v.10(1)
Feb 2012

v.10(2)
Apr 2012

v.10(3)
Jul 2012

v.10(4)
Oct 2012

Vol. 9
2011

v.9(1)
Apr 2011

v.9(2)
Aug 2011

v.9(3)
Dec 2011

Vol. 8
2010

v.8(1)
Jun 2010

v.8(2)
Dec 2010

Vol. 7
2009

v.7(1)
Jun 2009

v.7(2)
Dec 2009

Vol. 6
2008

v.6(1)
Jun 2008

v.6(2)
Dec 2008

Vol. 5
2007

v.5(1)
Jun 2007

v.5(2)
Dec 2007

Vol. 4
2006

v.4(1)
Jun 2006

v.4(2)
Dec 2006

Vol. 3
2005

v.3(1)
Jun 2005

v.3(2)
Dec 2005

Vol. 2
2004

v.2(1)
Apr 2004

v.2(2)
Dec 2004

Vol. 1
2003

v.1(1)
May 2003

v.1(2)
Nov 2003

ARTICLE & TOPICS

Article Category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

EDITORIAL POLICY

AUTHOR INFORMATION

Editorial Office: Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

prev

next

prev

next